nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—myometrium—ovarian cancer	0.0208	0.133	CbGeAlD
Gadopentetate dimeglumine—PGD—uterine cervix—ovarian cancer	0.0162	0.103	CbGeAlD
Gadopentetate dimeglumine—PGD—decidua—ovarian cancer	0.0154	0.0985	CbGeAlD
Gadopentetate dimeglumine—PGD—endometrium—ovarian cancer	0.0146	0.0935	CbGeAlD
Gadopentetate dimeglumine—PGD—gonad—ovarian cancer	0.0136	0.0867	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—ovarian cancer	0.0135	0.0862	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—ovarian cancer	0.0121	0.0775	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—ovarian cancer	0.0114	0.0731	CbGeAlD
Gadopentetate dimeglumine—PGD—female gonad—ovarian cancer	0.011	0.0705	CbGeAlD
Gadopentetate dimeglumine—PGD—vagina—ovarian cancer	0.011	0.0701	CbGeAlD
Gadopentetate dimeglumine—PGD—testis—ovarian cancer	0.00979	0.0625	CbGeAlD
Gadopentetate dimeglumine—PGD—lymph node—ovarian cancer	0.00709	0.0453	CbGeAlD
Gadopentetate dimeglumine—Migraine—Doxorubicin—ovarian cancer	0.000814	0.000965	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Paclitaxel—ovarian cancer	0.000813	0.000964	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Vinorelbine—ovarian cancer	0.000808	0.000958	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000805	0.000954	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Docetaxel—ovarian cancer	0.000803	0.000952	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Paclitaxel—ovarian cancer	0.000801	0.00095	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Paclitaxel—ovarian cancer	0.000801	0.00095	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000799	0.000948	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Paclitaxel—ovarian cancer	0.000799	0.000947	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—ovarian cancer	0.000798	0.000947	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Docetaxel—ovarian cancer	0.000798	0.000946	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000796	0.000944	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Topotecan—ovarian cancer	0.000793	0.00094	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000786	0.000932	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Paclitaxel—ovarian cancer	0.000784	0.000929	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vinorelbine—ovarian cancer	0.000782	0.000927	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Docetaxel—ovarian cancer	0.000781	0.000926	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Melphalan—ovarian cancer	0.000777	0.000921	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Paclitaxel—ovarian cancer	0.000775	0.000918	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000775	0.000918	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Docetaxel—ovarian cancer	0.000772	0.000915	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000768	0.000911	CcSEcCtD
Gadopentetate dimeglumine—Shock—Paclitaxel—ovarian cancer	0.000756	0.000896	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vinorelbine—ovarian cancer	0.000755	0.000896	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000755	0.000895	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000753	0.000893	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Epirubicin—ovarian cancer	0.000752	0.000892	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Paclitaxel—ovarian cancer	0.00075	0.000889	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Paclitaxel—ovarian cancer	0.000746	0.000885	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000745	0.000883	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000743	0.000881	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000739	0.000877	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Paclitaxel—ovarian cancer	0.000732	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vinorelbine—ovarian cancer	0.000726	0.000861	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vinorelbine—ovarian cancer	0.00072	0.000854	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vinorelbine—ovarian cancer	0.00072	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Paclitaxel—ovarian cancer	0.000718	0.000851	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vinorelbine—ovarian cancer	0.000716	0.000848	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Docetaxel—ovarian cancer	0.000716	0.000848	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Epirubicin—ovarian cancer	0.000714	0.000846	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Docetaxel—ovarian cancer	0.000701	0.000832	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.0007	0.00083	CcSEcCtD
Gadopentetate dimeglumine—Cough—Docetaxel—ovarian cancer	0.000696	0.000826	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—ovarian cancer	0.000696	0.000825	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Docetaxel—ovarian cancer	0.000691	0.00082	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Paclitaxel—ovarian cancer	0.00069	0.000818	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Docetaxel—ovarian cancer	0.000689	0.000817	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Epirubicin—ovarian cancer	0.000689	0.000817	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Paclitaxel—ovarian cancer	0.000685	0.000812	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Paclitaxel—ovarian cancer	0.000683	0.00081	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Docetaxel—ovarian cancer	0.000679	0.000805	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Docetaxel—ovarian cancer	0.000679	0.000805	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vinorelbine—ovarian cancer	0.000678	0.000804	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Epirubicin—ovarian cancer	0.000677	0.000803	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000675	0.0008	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Epirubicin—ovarian cancer	0.000669	0.000794	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Paclitaxel—ovarian cancer	0.000668	0.000792	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Docetaxel—ovarian cancer	0.000664	0.000788	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000663	0.000786	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Paclitaxel—ovarian cancer	0.000662	0.000785	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Epirubicin—ovarian cancer	0.00066	0.000783	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—ovarian cancer	0.00066	0.000783	CcSEcCtD
Gadopentetate dimeglumine—Pain—Paclitaxel—ovarian cancer	0.000657	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Paclitaxel—ovarian cancer	0.000657	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Docetaxel—ovarian cancer	0.000657	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000651	0.000772	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000651	0.000772	CcSEcCtD
Gadopentetate dimeglumine—Shock—Docetaxel—ovarian cancer	0.000641	0.00076	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Docetaxel—ovarian cancer	0.000639	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—ovarian cancer	0.000637	0.000756	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Docetaxel—ovarian cancer	0.000636	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000633	0.000751	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—ovarian cancer	0.000633	0.00075	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—ovarian cancer	0.000629	0.000746	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000628	0.000745	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—ovarian cancer	0.000626	0.000743	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Docetaxel—ovarian cancer	0.000621	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—ovarian cancer	0.00062	0.000735	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000619	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—ovarian cancer	0.000611	0.000724	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000611	0.000724	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Paclitaxel—ovarian cancer	0.00061	0.000724	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—ovarian cancer	0.000609	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—ovarian cancer	0.000609	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000608	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Paclitaxel—ovarian cancer	0.000607	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Paclitaxel—ovarian cancer	0.000607	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—ovarian cancer	0.000606	0.000719	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000603	0.000715	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—ovarian cancer	0.000596	0.000706	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000593	0.000703	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—ovarian cancer	0.000585	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—ovarian cancer	0.000585	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—ovarian cancer	0.000582	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—ovarian cancer	0.000581	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—ovarian cancer	0.000579	0.000686	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—ovarian cancer	0.000578	0.000685	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—ovarian cancer	0.000576	0.000683	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—ovarian cancer	0.000574	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—ovarian cancer	0.000574	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—ovarian cancer	0.000574	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—ovarian cancer	0.000566	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000566	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000565	0.00067	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000564	0.000668	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000562	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000562	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—ovarian cancer	0.000561	0.000666	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—ovarian cancer	0.000561	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—ovarian cancer	0.000561	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—ovarian cancer	0.000558	0.000662	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000557	0.000661	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—ovarian cancer	0.000557	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—ovarian cancer	0.000557	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—ovarian cancer	0.000555	0.000658	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—ovarian cancer	0.000552	0.000655	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—ovarian cancer	0.000551	0.000654	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Paclitaxel—ovarian cancer	0.000551	0.000654	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Paclitaxel—ovarian cancer	0.000544	0.000644	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—ovarian cancer	0.000542	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000541	0.000641	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—ovarian cancer	0.000538	0.000638	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—ovarian cancer	0.000537	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—ovarian cancer	0.000535	0.000634	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—ovarian cancer	0.000533	0.000632	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000533	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—ovarian cancer	0.000531	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000531	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—ovarian cancer	0.000528	0.000626	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—ovarian cancer	0.000527	0.000625	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Paclitaxel—ovarian cancer	0.000526	0.000623	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—ovarian cancer	0.000521	0.000617	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—ovarian cancer	0.000519	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—ovarian cancer	0.000517	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000516	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—ovarian cancer	0.000515	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—ovarian cancer	0.000515	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—ovarian cancer	0.000513	0.000609	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—ovarian cancer	0.000511	0.000606	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Paclitaxel—ovarian cancer	0.000508	0.000602	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—ovarian cancer	0.000501	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—ovarian cancer	0.000498	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—ovarian cancer	0.000495	0.000586	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—ovarian cancer	0.000489	0.000579	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Paclitaxel—ovarian cancer	0.000489	0.000579	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—ovarian cancer	0.000488	0.000578	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—ovarian cancer	0.000485	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Rash—Paclitaxel—ovarian cancer	0.000484	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Paclitaxel—ovarian cancer	0.000484	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—ovarian cancer	0.000483	0.000572	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—ovarian cancer	0.000482	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Headache—Paclitaxel—ovarian cancer	0.000481	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—ovarian cancer	0.00048	0.000569	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—ovarian cancer	0.000473	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—ovarian cancer	0.00047	0.000557	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—ovarian cancer	0.000467	0.000554	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—ovarian cancer	0.000466	0.000553	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—ovarian cancer	0.000465	0.000551	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Docetaxel—ovarian cancer	0.000461	0.000546	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—ovarian cancer	0.000458	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—ovarian cancer	0.000458	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—ovarian cancer	0.000458	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—ovarian cancer	0.000457	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Paclitaxel—ovarian cancer	0.000456	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000455	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—ovarian cancer	0.000449	0.000532	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—ovarian cancer	0.000448	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—ovarian cancer	0.000447	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—ovarian cancer	0.000446	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—ovarian cancer	0.000443	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000439	0.000521	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000438	0.000519	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—ovarian cancer	0.000435	0.000515	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—ovarian cancer	0.000432	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—ovarian cancer	0.000431	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—ovarian cancer	0.000431	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—ovarian cancer	0.000431	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—ovarian cancer	0.00043	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—ovarian cancer	0.000429	0.000508	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—ovarian cancer	0.000427	0.000506	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000425	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—ovarian cancer	0.000424	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—ovarian cancer	0.000424	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—ovarian cancer	0.000423	0.000501	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000421	0.000499	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—ovarian cancer	0.000419	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—ovarian cancer	0.000415	0.000492	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—ovarian cancer	0.000414	0.000491	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—ovarian cancer	0.000411	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—ovarian cancer	0.00041	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—ovarian cancer	0.00041	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—ovarian cancer	0.00041	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—ovarian cancer	0.000408	0.000484	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000406	0.000482	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.0004	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—ovarian cancer	0.0004	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000399	0.000473	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—ovarian cancer	0.000397	0.00047	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—ovarian cancer	0.000395	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—ovarian cancer	0.000394	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000393	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—ovarian cancer	0.000392	0.000464	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—ovarian cancer	0.00039	0.000463	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—ovarian cancer	0.000387	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—ovarian cancer	0.000387	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—ovarian cancer	0.000382	0.000453	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—ovarian cancer	0.00038	0.00045	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000379	0.00045	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—ovarian cancer	0.000379	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—ovarian cancer	0.000376	0.000445	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—ovarian cancer	0.000376	0.000445	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00037	0.000439	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—ovarian cancer	0.000365	0.000433	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—ovarian cancer	0.000362	0.00043	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—ovarian cancer	0.000362	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—ovarian cancer	0.000361	0.000428	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000359	0.000426	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—ovarian cancer	0.000353	0.000419	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000351	0.000416	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—ovarian cancer	0.00035	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—ovarian cancer	0.000349	0.000414	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—ovarian cancer	0.000348	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—ovarian cancer	0.000348	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—ovarian cancer	0.000347	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—ovarian cancer	0.000347	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000335	0.000397	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000332	0.000394	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—ovarian cancer	0.000324	0.000384	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—ovarian cancer	0.000323	0.000383	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—ovarian cancer	0.000321	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—ovarian cancer	0.000321	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—ovarian cancer	0.000315	0.000374	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—ovarian cancer	0.000311	0.000368	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—ovarian cancer	0.000301	0.000356	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000299	0.000355	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—ovarian cancer	0.000292	0.000346	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—ovarian cancer	0.00029	0.000344	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—ovarian cancer	0.000288	0.000341	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—ovarian cancer	0.000279	0.000331	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—ovarian cancer	0.000278	0.00033	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—ovarian cancer	0.000277	0.000328	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—ovarian cancer	0.000277	0.000328	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—ovarian cancer	0.000275	0.000326	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—ovarian cancer	0.000269	0.000319	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—ovarian cancer	0.000261	0.000309	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—ovarian cancer	0.000258	0.000306	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—ovarian cancer	0.000256	0.000304	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—ovarian cancer	0.000256	0.000304	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—ovarian cancer	0.000255	0.000302	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—ovarian cancer	0.000241	0.000286	CcSEcCtD
